Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Picard

Showing results (21-30 of 156) with videos related to

Pageof 16
Sort By:
Pharmacogenomics|January 23, 2016
New challenges and promises in solid organ transplantation pharmacogenetics: the genetic variability of proteins involved in the pharmacodynamics of immunosuppressive drugsLucie Pouché, Jana Stojanova, Pierre Marquet, et al.
Cellular and Molecular Life Sciences : CMLS|February 22, 2014
Electroneutral absorption of NaCl by the aldosterone-sensitive distal nephron: implication for normal electrolytes homeostasis and blood pressure regulationDominique Eladari, Régine Chambrey, Nicolas Picard, et al.
Pharmacogenomics|June 14, 2019
Big data in pharmacogenomics: current applications, perspectives and pitfallsClaire-Cécile Barrot, Jean-Baptiste Woillard, Nicolas Picard
Therapeutic Drug Monitoring|June 16, 2026
Unexpected Voriconazole Overexposure in a CYP2C19 Rapid Metabolizer Due to Inflammation-Induced Phenoconversion: A Short CommunicationGuillaume Drevin, Nicolas Picard, Marie Briet, et al.
Biometrics|April 9, 2010
A hierarchical bayesian model for spatial prediction of multivariate non-gaussian random fieldsPierrette Chagneau, Frédéric Mortier, Nicolas Picard, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 8, 2006
Metabolism of sirolimus in the presence or absence of cyclosporine by genotyped human liver microsomes and recombinant cytochromes P450 3A4 and 3A5Nicolas Picard, Nassim Djebli, François-Ludovic Sauvage, et al.
Mathematical Biosciences|March 3, 2009
Finding confidence limits on population growth rates: bootstrap and analytic methodsNicolas Picard, Pierrette Chagneau, Frédéric Mortier, et al.
Life Sciences|June 10, 2019
Multidrug resistance-associated protein 4 in pharmacology: Overview of its contribution to pharmacokinetics, pharmacodynamics and pharmacogeneticsJoseph Berthier, Hélène Arnion, Franck Saint-Marcoux, et al.
Therapie|March 1, 2017
Jean-Baptiste Woillard, Laurent Chouchana, Nicolas Picard, et al.
Pharmacogenomics|February 28, 2025
Posttransplantation diabetes mellitus (PTDM): pharmacological aspects and genetic predispositionsDorian Chastagner, Hélène Arnion, Clément Danthu, et al.
Pageof 16

Showing results (21-30 of 156) with videos related to

Sort By:
Pageof 16
Pharmacogenomics|January 23, 2016
New challenges and promises in solid organ transplantation pharmacogenetics: the genetic variability of proteins involved in the pharmacodynamics of immunosuppressive drugsLucie Pouché, Jana Stojanova, Pierre Marquet, et al.
Cellular and Molecular Life Sciences : CMLS|February 22, 2014
Electroneutral absorption of NaCl by the aldosterone-sensitive distal nephron: implication for normal electrolytes homeostasis and blood pressure regulationDominique Eladari, Régine Chambrey, Nicolas Picard, et al.
Pharmacogenomics|June 14, 2019
Big data in pharmacogenomics: current applications, perspectives and pitfallsClaire-Cécile Barrot, Jean-Baptiste Woillard, Nicolas Picard
Therapeutic Drug Monitoring|June 16, 2026
Unexpected Voriconazole Overexposure in a CYP2C19 Rapid Metabolizer Due to Inflammation-Induced Phenoconversion: A Short CommunicationGuillaume Drevin, Nicolas Picard, Marie Briet, et al.
Biometrics|April 9, 2010
A hierarchical bayesian model for spatial prediction of multivariate non-gaussian random fieldsPierrette Chagneau, Frédéric Mortier, Nicolas Picard, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 8, 2006
Metabolism of sirolimus in the presence or absence of cyclosporine by genotyped human liver microsomes and recombinant cytochromes P450 3A4 and 3A5Nicolas Picard, Nassim Djebli, François-Ludovic Sauvage, et al.
Mathematical Biosciences|March 3, 2009
Finding confidence limits on population growth rates: bootstrap and analytic methodsNicolas Picard, Pierrette Chagneau, Frédéric Mortier, et al.
Life Sciences|June 10, 2019
Multidrug resistance-associated protein 4 in pharmacology: Overview of its contribution to pharmacokinetics, pharmacodynamics and pharmacogeneticsJoseph Berthier, Hélène Arnion, Franck Saint-Marcoux, et al.
Therapie|March 1, 2017
Jean-Baptiste Woillard, Laurent Chouchana, Nicolas Picard, et al.
Pharmacogenomics|February 28, 2025
Posttransplantation diabetes mellitus (PTDM): pharmacological aspects and genetic predispositionsDorian Chastagner, Hélène Arnion, Clément Danthu, et al.
Pageof 16